OBiO Technology is a contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialised in gene and cell therapy. The company offers holistic research, development, and manufacturing solutions tailored for vectorology studies, functional genomics, process and analytical development, IND-enabling chemistry, manufacturing, and control (CMC), as well as clinical and commercial manufacturing. With a mission to "enable gene therapy for better lives," OBiO is dedicated to delivering high-quality services to global customers, guiding products from the bench to the clinic, and making a positive impact on populations worldwide. The company is committed to providing high-quality CDMO services for preclinical, IND, clinical, and commercial stages to consumers around the globe.

Services include:
- Cell and Gene Therapy
- Vectorology Studies
- Functional Genomics
- Process Development
- Analytical Development
- IND-Enabling CMC
- Clinical Manufacturing
- Commercial Manufacturing
- Cold Storage
- Finished Dosage Formulation
- Plasmid Supply
- Viral Vector Supply

OBiO Technology continues to advance the forefront of gene therapy, providing essential services that support the life sciences and pharmaceutical industries. For more information, please visit obio-tech.com.